Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec 19.
doi: 10.1038/s44321-025-00352-x. Online ahead of print.

Loss of CTLH component MAEA impairs DNA repair and replication and leads to developmental delay

Affiliations
Free article

Loss of CTLH component MAEA impairs DNA repair and replication and leads to developmental delay

Søren H Hough et al. EMBO Mol Med. .
Free article

Abstract

Ubiquitin E3 ligases play crucial roles in the DNA damage response (DDR) by modulating the turnover, localization, activation, and interactions of DDR and DNA replication proteins. We performed a CRISPR-Cas9 knockout screen focused on ubiquitin E3 ligases and related proteins with the DNA topoisomerase I inhibitor camptothecin. This led us to establish that MAEA, a core subunit of the CTLH E3 ligase complex, is a critical regulator of homologous recombination and the replication stress response. In tandem, we identified eight patients with variants in MAEA who present with a neurodevelopmental disorder that we term DIADEM (Developmental delay and Intellectual disability Associated with DEfects in MAEA). Analysis of patient-derived cell lines and mutation modeling reveal an underlying defect in HR-dependent DNA repair and replication fork restart and protection as a likely cause of disease. Mechanistically, we find that MAEA dysfunction hinders DNA repair by reducing the efficiency of RAD51 loading at sites of DNA damage, which we propose may contribute to the presentation of DIADEM by compromising genome integrity and cell division during development.

Keywords: DNA Repair; DNA Replication; Neurodevelopmental Disorder; Ubiquitin.

PubMed Disclaimer

Conflict of interest statement

Disclosure and competing interests statement. SPJ and YG work part-time at Insmed Innovation UK Ltd. SPJ is a founding partner of Ahren Innovation Capital LLP, a co-founder of Mission Therapeutics Ltd, and is a consultant and shareholder of Genome Therapeutics Ltd. The authors declare no other competing interests.

References

    1. Akinshin A (2023) AndreyAkinshin/perfolizer
    1. Awwad SW, Doyle C, Coulthard J, Bader AS, Gueorguieva N, Lam S, Gupta V, Belotserkovskaya R, Tran T-A, Balasubramanian S et al (2025) KLF5 loss sensitizes cells to ATR inhibition and is synthetic lethal with ARID1A deficiency. Nat Commun 16:480 - PubMed - PMC - DOI
    1. Awwad SW, Serrano-Benitez A, Thomas JC, Gupta V, Jackson SP (2023) Revolutionizing DNA repair research and cancer therapy with CRISPR–Cas screens. Nat Rev Mol Cell Biol 24:477–494
    1. Benslimane Y, Bertomeu T, Coulombe-Huntington J, McQuaid M, Sánchez-Osuna M, Papadopoli D, Avizonis D, Russo MDST, Huard C, Topisirovic I et al (2020) Genome-wide screens reveal that resveratrol induces replicative stress in human cells. Mol Cell 79:846–856.e8 - PubMed - DOI
    1. Bhat KP, Cortez D (2018) RPA and RAD51: fork reversal, fork protection, and genome stability. Nat Struct Mol Biol 25:446–453 - PubMed - PMC - DOI

LinkOut - more resources